Memorial Sloan Kettering Cancer Center 3rd Annual Advanced Practice Provider Oncology Symposium 2022

Description

+ Include: 61 videos + 48 pdfs, size: 15.1 GB

+ Target Audience: oncologist

+ Sample video: contact me for sample video

+ Information:

1. Identify innovate cancer treatment strategies for adult and pediatric cancers.
2. Explain initiatives that promote advance practice provider practice and professional development engagement
3. Discuss and address the challenges patients living with cancer face.
4. Describe the management of co-morbidities in patients undergoing cancer treatment.
5. Formulate optimal supportive care management for patients throughout the care continuum.
6. Recognize inequities in the screening, diagnosis, and management of cancer.

+ Topics:

Abdomen.pdf
Abdomen.ts
Ablative Radiation in the Treatment of Oligometastatic Cancers.pdf
Ablative Radiation in the Treatment of Oligometastatic Cancers.ts
Advances in Gene Therapy for the Treatment of Sickle Cell Disease.pdf
Advances in Gene Therapy for the Treatment of Sickle Cell Disease.ts
AYA Considerations What Really Makes Them a Unique Population.pdf
AYA Considerations What Really Makes Them a Unique Population.ts
Breast Surgery, Gynecologic Surgery and Female Sexual Health in the Oncology Setting Q&A.ts
CAIT (Cancer and Aging Interprofessional Team) Clinic.pdf
CAIT (Cancer and Aging Interprofessional Team) Clinic.ts
Cardiovascular Comorbidities in the Cancer Patient.pdf
Cardiovascular Comorbidities in the Cancer Patient.ts
Care of the Cancer Patient with Comorbidities Q&A.ts
Caring for Children Closer to Home.pdf
Caring for Children Closer to Home.ts
CBD Supplementation.pdf
CBD Supplementation.ts
Compassion Extubation.pdf
Compassion Extubation.ts
Complication in the Pediatric Oncology Patient Q&A.ts
Disparities and Dissatisfaction in Cancer Treatment in the LGBTQI+ Cancer Patient.pdf
Disparities and Dissatisfaction in Cancer Treatment in the LGBTQI+ Cancer Patient.ts
Early Referral Program for Optimization of Quality of Life and Shared Decision Making.pdf
Early Referral Program for Optimization of Quality of Life and Shared Decision Making.ts
Emerging and Innovative APP Leadership & Professional Development A Panel Discussion.ts
End of Life Rituals.pdf
End of Life Rituals.ts
Expanding Roles of CAR T Cell Therapy in Hematologic Malignancies.pdf
Expanding Roles of CAR T Cell Therapy in Hematologic Malignancies.ts
Female Sexual Health Effects After Surgery and Treatment Options.pdf
Female Sexual Health Effects After Surgery and Treatment Options.ts
Financial Toxicity.pdf
Financial Toxicity.ts
Functional Consequences of Pediatric Cancer Treatment.pdf
Functional Consequences of Pediatric Cancer Treatment.ts
Growth Hormone Use in Pediatric Cancer Survivors.pdf
Growth Hormone Use in Pediatric Cancer Survivors.ts
Hematologic Complication in the Pediatric Oncology Patient.pdf
Hematologic Complication in the Pediatric Oncology Patient.ts
Hematologic Complications in the Cancer Patient; Coagulopathy and Thrombotic Microangiopathies.pdf
Hematologic Complications in the Cancer Patient; Coagulopathy and Thrombotic Microangiopathies.ts
Hematologic Considerations Complications in the Cancer Patient and Benign Hematology Q&A.ts
HiltonHead2023-PodiatryProgram.pdf
Hyponatremia in the Oncology Patient.pdf
Hyponatremia in the Oncology Patient.ts
Immune Checkpoint Inhibitors Induced Diabetes.pdf
Immune Checkpoint Inhibitors Induced Diabetes.ts
Immune Thrombocytopenia (ITP) as a Complex Disease.pdf
Immune Thrombocytopenia (ITP) as a Complex Disease.ts
Impact of Geriatric Assessment on Oncologic Outcomes.pdf
Impact of Geriatric Assessment on Oncologic Outcomes.ts
Living with Cancer The Patient Experience Q&A.ts
Living with Pediatric Cancer and Survivorship Q&A.ts
Management for the Pediatric Oncology Patient Q&A.ts
Management of Malignancy Related Pain.pdf
Management of Malignancy Related Pain.ts
Management of Non-neutropenic Fever.pdf
Management of Non-neutropenic Fever.ts
MRI Spine.pdf
MRI Spine.ts
MSK Patient and Family Advisory Council for Quality (PFACQ).pdf
MSK Patient and Family Advisory Council for Quality (PFACQ).ts
MSKCC’s Cellular Therapy Service.pdf
MSKCC’s Cellular Therapy Service.ts
Novel Integrative Medicine Therapies for Patients with Chemotherapy-Induced Peripheral Neuropathy.pdf
Novel Integrative Medicine Therapies for Patients with Chemotherapy-Induced Peripheral Neuropathy.ts
Novel Therapies in the Treatment of Pediatric Hematologic and Solid Tumor Malignancies Q&A.ts
Opioid Reduction in GYN Patients Undergoing Laparotomy.pdf
Opioid Reduction in GYN Patients Undergoing Laparotomy.ts
Pain and Supportive Care Q&A.ts
Palliative Care in Africa.pdf
Palliative Care in Africa.ts
Pancytopenia Not Always Cancer – How to Work Up.pdf
Pancytopenia Not Always Cancer – How to Work Up.ts
PD-1 Blockade as Curative Intent in Mismatch Repair Deficient Locally Advanced Rectal Cancer.pdf
PD-1 Blockade as Curative Intent in Mismatch Repair Deficient Locally Advanced Rectal Cancer.ts
Pediatric Considerations in Radiologic Imaging.pdf
Pediatric Considerations in Radiologic Imaging.ts
PET Scan.pdf
PET Scan.ts
Pre-Surgical Testing.pdf
Pre-Surgical Testing.ts
Quality Interfaces with Practice Q&A.ts
Radiologic Interpretation in the Oncology Setting q&a.ts
Reconstructive Surgery with Perforator Flaps Following Mastectomy.pdf
Reconstructive Surgery with Perforator Flaps Following Mastectomy.ts
RISQ Utilization Simulation and Practice Change.pdf
RISQ Utilization Simulation and Practice Change.ts
Robotic Surgery for Early Stage Endometrial Cancer.pdf
Robotic Surgery for Early Stage Endometrial Cancer.ts
Same Day Discharge Pathway for Patients Undergoing Total Mastectomy with or without Reconstruction.pdf
Same Day Discharge Pathway for Patients Undergoing Total Mastectomy with or without Reconstruction.ts
Targeted Immunotherapy in Breast Cancer.pdf
Targeted Immunotherapy in Breast Cancer.ts
Targeted Therapies in Pediatric Hematologic Malignancies.pdf
Targeted Therapies in Pediatric Hematologic Malignancies.ts
Targeted Therapies in Pediatric Solid Tumors.pdf
Targeted Therapies in Pediatric Solid Tumors.ts
The Geriatric Cancer Patient Q&A.ts
The MSK Alliance Past, Present and Future.pdf
The MSK Alliance Past, Present and Future.ts
Updates and Approaches to Treating Metastatic Disease in the Solid Tumor Population Q&A.ts
Updates in Targeted Treatment Immunotherapy.pdf
Updates in Targeted Treatment Immunotherapy.ts
Use of Ketamine in the Pediatric Oncology Patient.pdf
Use of Ketamine in the Pediatric Oncology Patient.ts
Working Towards More Equitable Cancer Outcomes Addressing Social Determinants of Health.pdf
Working Towards More Equitable Cancer Outcomes Addressing Social Determinants of Health.ts